ArticleBlood advances2023
Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients.
Matthew R Schuelke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this paperpooled itcites it